WANG LAI (Global Head of R&D) sold 1.07K shares of BEONE MEDICINES LTD. on the open market
Open‑market sale worth $295.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001852291-26-000007
Officer· Global Head of R&D
Since Apr 2021
-1.07K
Net shares
Net seller
$295.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.07K disposed
Non-Derivative Transactions1
American Depositary Shares
Direct
Shares
−1.07K
Price / share
$276.74
Trade value
$295.55K
% of position
New position
6/23/2026
1.07K→0.00
Total
Net shares
−1.07K
Net value
-$295.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 6/23/2026 | S · Sale | −1.07K | $276.74 | $295.55K | New position | 1.07K | 0.00 |
| Total | −1.07K | -$295.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
RMB Shares
IndirectShares owned0.00
Ordinary Shares
DirectShares owned1.68M
Ordinary Shares
IndirectShares owned601.97K
Total
1.68M direct·601.97K indirect2.28M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| RMB Shares | 0.00 | Indirect |
| Ordinary Shares | 1.68M | Direct |
| Ordinary Shares | 601.97K | Indirect |
| Total | 2.28M | 1.68M direct·601.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported